Insider buying last 90 days
No open-market insider purchases were filed for CLX in the last 90 days.
From Form 4 filings, dated to when each was filed.
This week Clorox launched Clorox Purell ProCare, a new B2B platform combining CloroxPro with GOJO, the maker of Purell, aimed at professional and healthcare hygiene customers. Alongside this, Clorox raised its quarterly dividend to $1.25 per share, an annualized rate of $5, even as commentary pointed to an 85% payout ratio described by management as elevated, a 33% stock price decline over the past year, and continued inflation, weak volume growth and integration risk tied to the GOJO acquisition. The stock also drew attention for trading at a 14x forward P/E with a 6% dividend yield.
Clorox closed at $81.42, down 2.8%, and sits below both its 50-day average of $96.78 and 200-day average of $101.82, with the 50-day below the 200-day. The GekkoIndex reads 66.7, placing it in the Accumulation zone, though the reading has moved -5.3 over five days. Price stands 46.4% below the Gekko Fair Value of $152.03.
Over the next 20 trading days, the next earnings report falls on 3 November 2026, 35 days out, after the last quarter's EPS of $1.66 beat the $1.64 estimate and produced a 9.6% reaction. In the last 30 days there has been 1 unusual options signal, with call premium of $380,285 and no put premium. Consensus among 13 firms shows 0 buy, 9 hold and 4 sell ratings, with a consensus target of $100.76. Seasonally, the next 20 trading days have averaged -3.6% over 5 years, rising in 1 of them.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Clorox scores 4 supportive, 0 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $81.42 is below the 50-day ($96.78) and 200-day ($101.82) averages, and the 50-day is below the 200-day.
See the chart66.7, Accumulation
Reading 66.7 is in the Accumulation zone.
See the GekkoIndex46.4% below
Price is 46.4% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 30 days: 1 unusual options signal.
See smart moneyReports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings−3.6% on average
From this point in the calendar, the next 20 trading days averaged −3.6% over 5 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Clorox closed at $81.42 on Sep 28, 2026, −33.6% over the past year, inside a 52-week range of $80.84 to $128.90.
Use the left and right arrow keys to read daily values.
Put CLX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Clorox makes and sells a wide range of household and professional goods, spanning cleaning supplies, disinfectants, laundry additives, and personal care items. It is widely recognized for well-known names such as Clorox, Pine-Sol, Glad, Kingsford, Brita, and Burt's Bees, which appear on store shelves across many categories from home care to food storage to grilling.
The company organizes its operations into four segments: Health and Wellness, Household, Lifestyle, and International. Health and Wellness covers cleaning and disinfecting products for both homes and professional settings, along with vitamins and supplements sold under labels like RenewLife and NeoCell. Household focuses on cat litter, bags and wraps, and charcoal for the U.S. market, while Lifestyle includes dressings, sauces, natural personal care items, and water filtration systems. The International segment carries a similar mix of products under region-specific and global brand names. Clorox reaches shoppers through retailers, grocery and warehouse stores, pharmacies, pet shops, military exchanges, e-commerce sites, distributors, and its own sales force.
Founded in 1913, Clorox is headquartered in Oakland, California. Its shares are listed on the NYSE under the ticker CLX.
Clorox’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.7, in the Accumulation zone, down 5.3 points over five sessions.
Down 5.3 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 53 | −1.0% | +0.1% | ||
| Accumulation (current zone) | 310 | −0.2% | −1.5% | ||
| Neutral | 278 | −0.5% | −1.2% | ||
| Distribution | 29 | +0.8% | −0.9% | ||
| Selling | 2 | Too few readings yet | |||
Average CLX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Clorox trades 46.4% below Gekko Fair Value of $152.03, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Clorox shares are worth, recalculated every trading day.
$152.03
Gekko Fair Value, Sep 29, 2026
46.4% Undervalued
No open-market insider purchases were filed for Clorox, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CLX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CLX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Clorox has been buying back its own shares.
From company filings.
1signal, 100% of the flagged premium in calls.
Latest: Bullish flow on Sep 12, $380K in unusual premium.
2of the funds Gekko tracks hold CLX.
Clorox reports on Nov 3, 2026, after the close (35 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 3, 2026
Expected after the close, 35 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 3, 2026 | $1.66 est $1.64 | $1.95B est $1.91B | +9.6% |
| Apr 30, 2026 | $1.64 est $1.55 | $1.67B est $1.67B | −8.1% |
| Feb 3, 2026 | $1.39 est $1.43 | $1.67B est $1.64B | +4.0% |
| Nov 3, 2025 | $0.85 est $0.82 | $1.43B est $1.40B | −1.8% |
| Jul 31, 2025 | $2.87 est $2.20 | $1.99B est $1.93B | −2.4% |
| May 5, 2025 | $1.45 est $1.55 | $1.67B est $1.72B | −2.9% |
| Feb 3, 2025 | $1.55 est $1.39 | $1.69B est $1.76B | −6.6% |
| Oct 30, 2024 | $1.86 est $1.41 | $1.76B est $1.65B | +1.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Clorox is $100.76, +23.8% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Bank of America Securities | $100 | +22.8% |
| Sep 11 | Citi | $97 | +19.1% |
| Sep 11 | Evercore ISI | $99 | +21.6% |
| Sep 11 | Bank of America Securities | $100 | +22.8% |
| Sep 11 | Wells Fargo | $90 | +10.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Clorox averaged −3.6% across the last 5 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.7% | 0 of 5 |
| Next 10 trading days | −3.3% | 0 of 5 |
| Next 15 trading days | −2.8% | 0 of 5 |
| Next 20 trading days | −3.6% | 1 of 5 |
| Next 30 trading days | −1.1% | 3 of 5 |
For scale, CLX’s typical 20-trading-day move in either direction is about 4.7%.
Clorox’s market cap is $9.85B, with a P/E ratio of 17.4 and revenue of $6.72B over the last twelve months.
Coverage of Clorox this week reads neutral: 8 positive, 9 neutral and 5 negative headlines.
Clorox’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 11.3% below |
| CLColgate-Palmolive | Accumulation | 1.8% below |
| ELEstee Lauder Companies | Neutral | 5.7% above |
| KVUEKenvue | Accumulation | 19.5% below |
| KMBKimberly-Clark | Accumulation | 14.9% below |
| CHDChurch & Dwight | Accumulation | 3.8% below |
A peer links to its own page where one exists.
Clorox’s market cap is $9.85B at the Sep 28, 2026 close of $81.42, with 120.9M shares outstanding. The shares trade on a P/E ratio of 17.4.
The consensus analyst 12-month price target for Clorox is $100.76, +23.8% from the last close. Of the 13 firms that rated the stock in the last 90 days, 0 rate it a buy, 9 a hold and 4 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Clorox is undervalued: the Sep 28, 2026 close of $81.42 is 46.4% below Gekko Fair Value of $152.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Clorox is expected to report on Nov 3, 2026, after the market closes (35 days away). Analysts expect earnings of $1.11 per share on revenue of $1.88B. Clorox beat the earnings estimate in 6 of its last 8 reports, moving 4.6% on average across the report.
Clorox’s 52-week high is $128.90 and its 52-week low is $80.84; it closed at $81.42 on Sep 28, 2026, −33.6% over the past year. Over the last five years the shares peaked at $186.86 on Jan 14, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
Gekko flagged 1 unusual options signal in Clorox over the last 30 days, with $380K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Sep 12, 2026 with $380K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.